Rhythm Pharma CFO Hunter C. Smith disposes of common shares worth $6.61 million
RYTM•Post-transaction holdings
Directly held common stock ended at 114,024 shares.
Employee stock options ended at 3,813 shares.
CFO exercised options and sold shares
Rhythm Pharmaceuticals CFO Hunter C. Smith exercised employee stock options for 57,187 shares at $25.79 on Aug. 31, 2026.
He sold 62,774 shares the same day at weighted average prices of $104.59, $105.37, and $106.2.
